Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Medicina Clinica
|
September 26, 1987
[Serum immunoglobulins in parenteral drug addicts]
E Aguilar Ligorit, J Guix García, A Sánchez Mañez, et al.
Tumori
|
October 31, 1987
Adjuvant chemotherapy with adriamycin, fluorouracil, cyclophosphamide, methotrexate, with or without tamoxifen in operable breast cancer
A Lluch-Hernandez, A Cervantes-Ruiperez, A Anton-Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer
D Isla, R Rosell, J J Sánchez, et al.
Medicina Clinica
|
May 6, 1989
[Thrombopenic purpura associated with human immunodeficiency virus infection. Analysis of 24 cases]
E Aguilar Ligorit, J Guix García, I Benet Monforte, et al.
Revue Des Maladies Respiratoires
|
February 3, 2007
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer
R Rosell, T Moran, M Fernanda Salazar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations
M Monzó, R Rosell, J J Sánchez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 3, 2005
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer
C Camps, E Felip, J M Sanchez, et al.
Cancer Chemotherapy and Pharmacology
|
October 12, 2012
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer
M Provencio, C Camps, M Cobo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
F Cardenal, M P López-Cabrerizo, A Antón, et al.
Clinical Lung Cancer
|
January 22, 2004
Preoperative high-dose cisplatin versus moderate-dose cisplatin combined with ifosfamide and mitomycin in stage IIIA (N2) non small-cell lung cancer: results of a randomized multicenter trial
E Felip, R Rosell, V Alberola, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Medicina Clinica
|
September 26, 1987
[Serum immunoglobulins in parenteral drug addicts]
E Aguilar Ligorit, J Guix García, A Sánchez Mañez, et al.
Tumori
|
October 31, 1987
Adjuvant chemotherapy with adriamycin, fluorouracil, cyclophosphamide, methotrexate, with or without tamoxifen in operable breast cancer
A Lluch-Hernandez, A Cervantes-Ruiperez, A Anton-Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer
D Isla, R Rosell, J J Sánchez, et al.
Medicina Clinica
|
May 6, 1989
[Thrombopenic purpura associated with human immunodeficiency virus infection. Analysis of 24 cases]
E Aguilar Ligorit, J Guix García, I Benet Monforte, et al.
Revue Des Maladies Respiratoires
|
February 3, 2007
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer
R Rosell, T Moran, M Fernanda Salazar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations
M Monzó, R Rosell, J J Sánchez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 3, 2005
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer
C Camps, E Felip, J M Sanchez, et al.
Cancer Chemotherapy and Pharmacology
|
October 12, 2012
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer
M Provencio, C Camps, M Cobo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
F Cardenal, M P López-Cabrerizo, A Antón, et al.
Clinical Lung Cancer
|
January 22, 2004
Preoperative high-dose cisplatin versus moderate-dose cisplatin combined with ifosfamide and mitomycin in stage IIIA (N2) non small-cell lung cancer: results of a randomized multicenter trial
E Felip, R Rosell, V Alberola, et al.
Page
of 8